-
Alternative_name
6-(4-hydroxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-2-naphthalenecarboxylic acid; AHPN
-
Description
CD437 is the adamantyl arotinoid of the retinoid-related molecule family that acts as a selective agonist of retinoic acid receptor (RAR)γ (Kds = 6.5 μM, 2.5 μM, and 77 nM for RARα, β, and γ, respectively). CD437 is cytotoxic to the acute myeloid leukemia cell line NB4 (EC₅₀ = 0.17 μM), inducing DNA damage by producing DNA double strand breaks. CD437 also induces cell cycle arrest and apoptosis in various other cancer cells including melanoma, breast, non-small lung, and prostate cancer cells through RAR-dependent and -independent signaling pathways. Treatment of mouse embryonic fibroblasts (MEFs) with CD437 early in the reprogramming process significantly increases reprogramming efficiency up to 20-fold.
-
CAS Number
125316-60-1
-
Structure Available
Y
-
Salt Form
No
-
Molecular Formula
C₂₇H₂₆O₃
-
Molecular Weight
398.49
-
Cell Permeable
Yes
-
Purity
>95%
-
Solubilities
DMSO (>10 mg/ml)
-
Handling
Protect from air and light
-
Tag Line
A selective RARgamma agonist and stem cell fate modulator
-
Storage Condition
-20 ̊C
-
Shipping Condition
Gel pack
-
Shelf Life
36 months
-
MDL Number
MFCD3106506
-
PubChem CID
135411
-
-
SMILES
C1C2CC3CC1CC(C2)(C3)C4=C(C=CC(=C4)C5=CC6=C(C=C5)C=C(C=C6)C(=O)O)O
-
InChi
InChI=1S/C27H26O3/c28-25-6-5-22(20-1-2-21-11-23(26(29)30)4-3-19(21)10-20)12-24(25)27-13-16-7-17(14-27)9-18(8-16)15-27/h1-6,10-12,16-18,28H,7-9,13-15H2,(H,29,30)
-
InChi Key
LDGIHZJOIQSHPB-UHFFFAOYSA-N
-
-
MSDS Available
Yes